Project Grant HT9425261E242
- Federal Grant Award Summary The University of Utah's Office of Sponsored Projects received a $369,872 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, with an ultimate completion date of August 31, 2027. The award supports basic and applied biomedical research focused on temporal coding of the human auditory nerve, a hypothesis-driven investigation designed to advance healthcare solutions...
- Federal Project Grant Award Summary The University of Utah's Office of Sponsored Projects received a $695,255 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2026 through July 31, 2029. The award supports research examining "The Value of Hypertension Control to Prevent Dementia and Enhance Readiness: Generating Evidence from DOD-VHA Data, Patient Preferences and Health Economics." The project...
- This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
- Federal Project Grant Award Summary The University of Virginia received a $1.7M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded May 1, 2026, with completion scheduled for April 30, 2029. This award supports research focused on preserving lung integrity and harnessing inflammation to treat burn-induced inhalation injury. The research will be conducted at the university's Charlottesville, Virginia campus and is...
- The University of Utah has been awarded a $824,512 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from June 1, 2024 to May 31, 2027, will fund research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." This project aims to leverage digital pathology techniques to improve the prediction of treatment outcomes for patients with hormone-sensitive...
- The University of Utah has been awarded a $1,232,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETING IRON-SULFUR CLUSTER ASSEMBLY A NOVEL VULNERABILITY IN KIDNEY CANCER," will fund research focused on developing new treatment approaches for kidney cancer. The award period runs from July 1, 2024, through June 30, 2028. This federal grant program supports a range of biomedical...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $319,800 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2028. The award funds research on novel hypoxia-inducible factor 2 (HIF-2) regulators and therapeutic targets for kidney cancer, conducted at the institution's Dallas, Texas campus. This research initiative...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Stanford University a $832,270 Project Grant effective July 1, 2025, through June 30, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports high-throughput in vivo lung cancer pharmacogenomics research conducted at Stanford's Palo Alto, California facility. This research initiative will deliver advanced biomedical research services focused on investigating innovative medical...
- Federal Project Grant Award Summary The University of Utah, through its Office of Sponsored Projects, received a $1.56M project grant from the Defense Health Agency under the Military Health Services Research (MHSR) Program (CFDA 12.007) awarded September 1, 2025, with completion by August 31, 2027. The project, titled "Using Telehealth to Improve Musculoskeletal Care Through Expanded Physical Therapy Access: The TELE-MC Trial," is designed to advance healthcare delivery efficiency...
- The University of Utah has been awarded a $1,128,787 Project Grant by the Defense Health Agency, an agency of the U.S. Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The grant is for a 3-year project titled "OPTIMIZING QUANTITATIVE PHASE IMAGING FOR PREDICTING BREAST CANCER THERAPY RESPONSE," with a performance period from January 15, 2024 to January 14, 2027. The funded research aims to develop and evaluate advanced quantitative phase...
The University of Utah's Office of Sponsored Projects received a $1.395 million project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2029. The award funds research investigating exposure-induced lung injury and interventions to prevent early lung cancer progression. This research aligns with the DHA's mission to transform healthcare for service members and the American public through innovative biomedical solutions, with particular emphasis on hypothesis-driven investigations addressing military health priorities and broader public health objectives. The University of Utah will deliver research and development services centered on understanding lung injury mechanisms related to environmental or occupational exposures and developing preventive interventions for early-stage lung cancer. As a major research institution with extensive experience managing federally-funded biomedical research across multiple agencies, the university will conduct this work at its Salt Lake City, Utah location. The three-year performance period is consistent with typical award timelines under the Military Medical Research and Development program, which generally supports research projects ranging from two to four years in duration.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.4m | 5/20/26 |